Codes / ICD10CM / C79.89

C79.89 Secondary malignant neoplasm of other specified sites

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Secondary malignant neoplasm of other specified sites
  • ICD-10 Code: C79.89

Summary

Secondary malignant neoplasm of other specified sites refers to cancer that has metastasized from a primary tumor to locations in the body that are not categorized elsewhere in the ICD-10-CM classification. This condition indicates advanced disease and requires evaluation to identify the primary source and guide management.

Causes

Secondary malignant neoplasms occur when cancer cells from a primary tumor detach, travel through the bloodstream or lymphatic system, and establish new tumors in distant sites. The specific sites involved depend on the primary cancer type and its typical metastatic patterns.

Risk Factors

  • History of primary cancer
  • Advanced stage of the primary tumor
  • Lack of effective primary cancer treatment
  • Weakened immune system
  • Genetic predisposition to aggressive cancer types

Symptoms

  • Vary depending on the organs or tissues affected by metastasis
  • General symptoms may include fatigue, unexplained weight loss, and loss of appetite
  • Specific symptoms relate to the secondary site (e.g., pain, neurological changes, or organ dysfunction)

Diagnosis

Imaging tests (CT, MRI, PET scans) are used to identify metastatic lesions. Biopsy of suspected tissue confirms the presence of cancer cells and determines their origin.

Treatment Options

Treatment depends on the primary cancer type, the extent of metastasis, and the patient’s overall health. Options may include systemic therapies (chemotherapy, targeted therapy, immunotherapy), radiation therapy for localized control, and supportive care to manage symptoms.

Prognosis and Follow-Up

Prognosis varies based on the primary cancer, the number and location of metastases, and treatment response. Regular follow-up with imaging and clinical assessments is essential to monitor disease progression and adjust management.

Complications

  • Organ dysfunction due to metastatic involvement
  • Pain or neurological symptoms
  • Reduced quality of life
  • Treatment-related side effects (e.g., fatigue, nausea)

Lifestyle & Prevention

  • Maintain a healthy lifestyle to support overall well-being during treatment
  • Follow recommended cancer screening guidelines for early detection of primary tumors
  • Adhere to prescribed therapies to reduce the risk of metastasis

When to Seek Professional Help

Seek medical attention if new or worsening symptoms (e.g., persistent pain, unexplained weight loss, or organ-specific issues) occur, as these may indicate disease progression or complications.

Tips for Medical Coders

Document the specific site of secondary malignancy clearly, as this code is used for metastases to sites not classified elsewhere. Ensure the primary cancer and any relevant treatment history are documented to support accurate coding and clinical context.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

C79.89 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.